OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← BCM management

Full background report

Edmar Medeiros

Technical Manager (recent secondary listing; current status unconfirmed)

Career chronology

Personal achievements

Named technical manager and report contributor

2020–2026 · issuer reported · medium materiality

BBX announced the appointment of chemical engineer Edmar Medeiros as technical manager in July 2020, and its 2024 Três Estados statement identifies him as a test-result compiler. A secondary profile updated in October 2026 still lists that title; the current mandate was not confirmed by a dated recent issuer release.

Attribution: Individual involvement documented. The named roles and contribution are issuer-reported; personal economic performance is not measured.

Relevance: Evidence of processing and testing involvement, with current role uncertain.

BBX FY2021 annual report (printed p.11, corporate activities); Final Três Estados bioleach report (p.3, competent person statement); BCM company profile and key executives (Key executives and last-updated date)

Business failures and setbacks

Earlier bioleach work and a disputed supplier invoice

2023–2026 · issuer reported · medium materiality

The FY2026 report says the Brazilian subsidiary could not replicate the supplier’s bacterial-leaching results in Brazil, terminated the licence in June 2024, and disputes a US$350,000 supplier invoice. The annual report does not identify who made the technical or commercial decisions.

Attribution: Role overlaps event; causation unproven. Technical-manager involvement is documented in 2024; no personal failure, contractual fault or decision is established.

Relevance: Relevant to assessing prior processing technology development.

Final Três Estados bioleach report (p.3, technical manager); FY2026 annual report (printed p.48, note 13(b))

Suitability for the current role

Chemical-engineering and processing background

31 October 2026 · analyst inference · medium materiality

Issuer statements identify a chemical engineer in a technical and assay role, relevant to metallurgical work. The plant’s commercial-scale project outcome and individual contribution remain unproven.

Attribution: Responsibility not applicable. Analyst inference from reported role, not a claim of production delivery.

Relevance: Relevant to process development.

BBX FY2021 annual report (printed p.11); Final Três Estados bioleach report (p.3)

Evidence gaps

  • No dated issuer confirmation of continued technical-management role after January 2024; recent third-party list may be stale.

  • Full prior employment, degree-awarding institution, and independent professional credentials not established.

  • The source does not attribute company bioleach or litigation outcome personally; original supplier and court records unavailable.